CORC

在结果中检索

CORC

浏览/检索结果: 共32条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping
收藏  |  浏览/下载：31/0  |  提交时间：2022/05/16
MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAF(V600E) : An In Vitro 期刊论文
MOLECULAR THERAPY-ONCOLYTICS, 2019, 卷号: 12
作者:  Cheng, Lingxiao;  Cheng, Lin;  Liu, Min;  Chen, Libo;  Fu, Hao
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma 期刊论文
ACTA PHARMACOLOGICA SINICA, 2019, 卷号: Vol.40 No.2, 页码: 268-278
作者:  Gao, Ming-zhao;  Wang, Hong-bin;  Chen, Xiang-ling;  Cao, Wen-ting;  Fu, Li
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/13
A high-performance liquid chromatography-tandem mass spectrometry method for the determination of lifrafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine and its application in clinical pharmacokinetic study 期刊论文
2019, 卷号: 166, 页码: 20-29
作者:  Yao, Xueting;  Song, Ling;  Liu, Yang;  Wang, Huanhuan;  Liu, Jie
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
aberrantmodulationofribosomalproteins6phosphorylationconfersacquiredresistancetomapkpathwayinhibitorsinbrafmutantmelanoma 期刊论文
中国药理学报英文版, 2019, 卷号: 040, 期号: 002, 页码: 268
作者:  Mingzhao Gao;  Hongbin Wang;  Xiangling Chen;  Wenting Cao;  Li Fu
收藏  |  浏览/下载：6/0  |  提交时间：2020/07/01
Identification of recurrent USP48 and BRAF mutations in Cushing's disease 期刊论文
NATURE COMMUNICATIONS, 2018, 卷号: 9
作者:  Chen, Jianhua;  Jian, Xuemin;  Deng, Siyu;  Ma, Zengyi;  Shou, Xuefei
收藏  |  浏览/下载：117/0  |  提交时间：2019/01/08
Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy 期刊论文
ACTA PHARMACEUTICA SINICA B, 2018, 卷号: 8, 期号: 4, 页码: 552-562
作者:  Liu, Feifei;  Yang, Xiaotong;  Geng, Meiyu;  Huang, Min
收藏  |  浏览/下载：33/0  |  提交时间：2019/01/08
Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma 期刊论文
Acta pharmacologica Sinica, 2018
作者:  Gao, Ming-Zhao;  Wang, Hong-Bin;  Chen, Xiang-Ling;  Cao, Wen-Ting;  Fu, Li
收藏  |  浏览/下载：23/0  |  提交时间：2019/01/08
BRAF and EGFR inhibitors synergize to increase cytotoxic effects and decrease stem cell capacities in BRAF(V600E)-mutant colorectal cancer cells 期刊论文
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2018, 卷号: 50, 期号: 4
作者:  Wu, Zhenhua;  Huang, Mingzhu;  Gong, Yiwei;  Lin, Chen;  Guo, Weijian
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Discovery of 2-(aminopyrimidin-5-yl)-4-(morpholin-4-yl)-6- substituted triazine as PI3K and BRAF dual inhibitor. 期刊论文
Future medicinal chemistry, 2018, 卷号: 10, 页码: 2445-2455
作者:  Wang Hui-Yan;  Shen Ying;  Zhang Hao;  Hei Yuan-Yuan;  Zhao Hong-Yi
收藏  |  浏览/下载：4/0  |  提交时间：2019/11/19

©版权所有 ©2017 CSpace - Powered by CSpace